These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12763508)

  • 21. Clostridium difficile Infection in Production Animals and Avian Species: A Review.
    Moono P; Foster NF; Hampson DJ; Knight DR; Bloomfield LE; Riley TV
    Foodborne Pathog Dis; 2016 Dec; 13(12):647-655. PubMed ID: 27602596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.
    Johal SS; Hammond J; Solomon K; James PD; Mahida YR
    Gut; 2004 May; 53(5):673-7. PubMed ID: 15082585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile.
    Stoddart B; Wilcox MH
    Curr Opin Infect Dis; 2002 Oct; 15(5):513-8. PubMed ID: 12686885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
    Settle CD; Wilcox MH; Fawley WN; Corrado OJ; Hawkey PM
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1217-23. PubMed ID: 9882029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent Clostridium difficile colitis.
    Joyce AM; Burns DL
    Compr Ther; 2004; 30(3):160-3. PubMed ID: 15793316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotics and Clostridium difficile.
    Freeman J; Wilcox MH
    Microbes Infect; 1999 Apr; 1(5):377-84. PubMed ID: 10602670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic prescribing policy and Clostridium difficile diarrhoea.
    O'Connor KA; Kingston M; O'Donovan M; Cryan B; Twomey C; O'Mahony D
    QJM; 2004 Jul; 97(7):423-9. PubMed ID: 15208430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile diarrhea and colitis: a clinical overview.
    Taege AJ; Adal KA
    Cleve Clin J Med; 1999 Sep; 66(8):503-7. PubMed ID: 10486998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile colitis--diagnosis and therapy.
    Lapiński TW; Prokopowicz D; Dare A
    Rocz Akad Med Bialymst; 1996; 41(2):176-82. PubMed ID: 9020528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
    Kundrapu S; Sunkesula VC; Jury LA; Cadnum JL; Nerandzic MM; Musuuza JS; Sethi AK; Donskey CJ
    BMC Infect Dis; 2016 Apr; 16():159. PubMed ID: 27091232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile colitis: a review.
    Moudgal V; Sobel JD
    Hosp Pract (1995); 2012 Feb; 40(1):139-48. PubMed ID: 22406889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis.
    Friedman G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):763-79. PubMed ID: 23101686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospital-acquired Clostridium difficile infection amongst ICU and burn patients in Kuwait.
    Rotimi VO; Mokaddas EM; Jamal WY; Verghese TL; el-Din K; Junaid TA
    Med Princ Pract; 2002; 11(1):23-8. PubMed ID: 12116691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile infection: pathophysiology and diagnosis.
    Bartlett JG
    Semin Gastrointest Dis; 1997 Jan; 8(1):12-21. PubMed ID: 9000498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of clostridium difficile colitis in the critical care setting.
    Musher DM; Aslam S
    Crit Care Clin; 2008 Apr; 24(2):279-91, viii. PubMed ID: 18361946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.
    Andréjak M; Schmit JL; Tondriaux A
    Drug Saf; 1991; 6(5):339-49. PubMed ID: 1930740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model.
    Baines SD; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2005 Jun; 55(6):974-82. PubMed ID: 15860551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.